OXIDATIVE STRESS IN IMMUNE RESPONSE
OXIDATIVE STRESS IN IMMUNE RESPONSE
Oxidative
stress is an imbalance of free radicals and antioxidants in the body, which can
lead to cell and tissue damage. Oxidative stress occurs naturally and plays a
role in the aging process.
Disturbances in the
normal redox state of cells can cause toxic effects through the production of
peroxides and free radicals that damage all components of the cell, including
proteins, lipids, and DNA. Oxidative stress from oxidative metabolism causes base
damage, as well as strand breaks in DNA. Base damage is mostly indirect and
caused by reactive oxygen species (ROS) generated, e.g. O2− (superoxide
radical), OH (hydroxyl radical) and H2O2 (hydrogen peroxide) [1]. Further,
some reactive oxidative species act as cellular messengers in redox signaling.
Thus, oxidative stress can cause disruptions in normal mechanisms of cellular
signaling.
In humans, oxidative
stress is thought to be involved in the development of ADHD, cancer,Parkinson's
disease, Lafora disease, Alzheimer's disease, atherosclerosis, heart failure,and
myocardial infarction. Oxidative stress is a
normal occurrence during the immune system’s inflammatory response to infection
or injury. Inflammation plays a vital role in the body’s response to pathogens
and tissue damage. However, considerable evidence now points to oxidative
stress from chronic inflammation as a contributing factor in a number of health
and production disorders in cattle [2].
OXIDATIVE
STRESS AND AGING RELATED DISEASE
Oxidative stress, cellular senescence, and consequently, SASP factors
are involved in several acute and chronic pathological processes, such as CVDs,
acute and chronic kidney disease (CKD), neurodegenerative diseases (NDs),
macular degeneration (MD), biliary diseases, and cancer. Cardiovascular (CV)
risk factors (ie, obesity, diabetes, hypertension, and atherosclerosis) are
associated with the inflammatory pathway mediated by IL-1α, IL-6, IL-8, and
increased cellular senescence [3].
Moreover, vascular calcification is linked to an SASP-driven
osteoblastic transdifferentiation of senescent smooth muscle cells. In many
neurodegenerative conditions, including Alzheimer’s disease (AD), brain tissue
biopsies show increased levels of p16, MMP, and IL-6 [4]. Chronic obstructive
pulmonary disease, biliary cirrhosis, cholangitis, and osteoarthritis share
several damaging SASP profiles including IL-6, IL-8, and MMP.Diabetes mellitus
(type 1 and 2) is a metabolic disease associated with increased formation of
free radicals and decreased antioxidant potential, leading to macro- and
microvascular complications. The precise mechanism by which oxidative stress
may accelerate the development of complications in diabetes is only partly
known. Oxidant stress in type 2 diabetes (T2D) promotes prothrombotic
reactions, leading to CV complications.
Macrophages (ΜΦs) are part of the innate immune system and can differentiate into several subtypes with opposite functions in the course of the immune and inflammatory response. Their activation plays a central role in both innate and acquired immunity, which suggests a tightly regulated switch in response to environmental conditions that promote ΜΦ recruitment via tissue infiltration. The high plasticity of ΜΦs enables these cells to respond and adapt to the specific requirements of the inflamed area. The functions of ΜΦs include host defense against pathogens, phagocytosis and pathogen killing, bone dynamics, antigen presentation, local inflammatory reactions, wound healing, blood lipid homeostasis and tissue remodelling. Reactive oxygen and nitrogen species (ROS and RNS, respectively) are also prototypical ΜΦ mediators that play a central role in effector functions. ΜΦs increase ROS and RNS production after exposure to a number of different signals including pathogen-derived or damage associated molecular patterns (PAMPs, such as lipopolysaccharide or DAMPs, such as high-mobility box 1 protein, nucleotides, and DNA, respectively), cytokines (e.g. TNFα, IFNγ), metabolic stress (e.g. hyperglycemia, advanced glycation endproducts, oxidized lipoproteins), endoplasmic reticulum stress, unfolded protein accumulation (unfolded protein response; UPR), and various nanoparticles. This exacerbated release of ROS and RNS constitutes the oxidative burst: a defense mechanism initiated by ΜΦs to destroy pathogens thanks to the bactericidal activity of ROS and RNS.
Fig 1: Mechanisms of reactive oxygen and nitrogen
species generation in macrophages
ROS are generated via enzymatic reactions mediated by NADPH oxidase 2
(NOX2) and xanthine oxidase (XO) and/or as a result of mitochondrial
respiratory dysfunction. RNS production is mainly driven by NOS2, whose main
product, NO, has either pro- or anti-apoptotic and survival functions,
depending on the generation rate. Both ROS and RNS dramatically affect cell
metabolism, DNA integrity, and macrophage viability.
The most important sources of ROS in activated ΜΦs are NADPH oxidase 2
(NOX2), xanthine oxidase (XO), and the mitochondrial electron transport chain.
Superoxide (O2●-), and hydrogen peroxide (H2O2)
generated by these systems play signaling roles, but may also contribute to
cell dysfunction and death [5].
REFERENCE
[1]
Birnboin, H. C. (1986). "DNA strand breaks in human leukocytes induced by
super-oxide anion, hydrogen peroxide and tumor promoters are repaired slowly
compared to breaks induced by ionizing radiation". Carcinogenesis. 7:
1511–1517. doi:10.1093/carcin/7.9.151.
[2]
Julia Hamann, D.V.M.” Oxidative stress: Impact on dairy health and immune
function” Published on: 8/10/2015.
[3]
Chandrasekaran
A, Idelchik MDPS, Melendez JA. Redox control of senescence and age-related
disease. Redox Biol. 2017;11:91–102.
[4] Burton DGA, Matsubara H, Ikeda K. Pathophysiology
of vascular calcification: pivotal role of cellular senescence in vascular
smooth muscle cells. Exp Gerontol.
[5] László Virág,a,
Rafael I. Jaén, Zsolt Regdon, Lisardo Boscá, and Patricia Prieto.”
Self-defense
of macrophages against oxidative injury: Fighting for their own survival” Redox
Biol.2019 Sep; 26: 101261. Published online 2019 Jun
28.doi:10.1016/j.redox.2019.101261.
Comments